Plant-Based chondroitin puts joint health to the test
NCT ID NCT07727174
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This study investigates whether chondroitin sulfate from two sources—fermentation (MyCondro™) and bovine (cow)—can influence the health of cartilage, joint capsule, and bone cells. Ten healthy men will take each supplement, and their blood will be tested on human cells in the lab to measure effects on cell growth, metabolism, and inflammation. The goal is to understand how these supplements might support joint health at a cellular level.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chondroitin sulfate from fermentation (MyCondro™) and bovine chondroitin sulfate
- What this could lead to
- If the study shows biological activity, it could support developing plant-based chondroitin supplements for joint health.
- What could go wrong
- This is a very small, early-stage study in healthy men, not people with joint problems. Results may not translate to real-world benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JOINT HEALTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre d'investigation clinique | CIC
Clermont-Ferrand, Cedex 1, 63003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.